HIV Diagnostics Market Size to Hit USD 2.24 Billion by 2035

Introduction

The global HIV diagnostics market is experiencing consistent growth, driven by rising awareness about HIV/AIDS, increasing government initiatives, and expanding healthcare infrastructure worldwide. Early detection and timely diagnosis remain critical in controlling the spread of HIV and improving patient outcomes.

According to recent market insights, the global HIV diagnostics market size was valued at USD 1.34 billion in 2025 and is projected to grow from USD 1.41 billion in 2026 to approximately USD 2.24 billion by 2035, expanding at a CAGR of 5.26% during the forecast period.

Read Also: Joint Replacement Market

What is the HIV Diagnostics Market?

The HIV diagnostics market encompasses the development, manufacturing, and distribution of diagnostic tools, equipment, and services used to detect Human Immunodeficiency Virus (HIV). These diagnostics identify HIV antibodies, antigens (such as p24), or viral RNA in blood or oral fluid samples.

Testing technologies include ELISA, rapid diagnostic tests, and nucleic acid testing methods, which are widely used across hospitals, laboratories, and home care settings. Increasing emphasis on early detection and preventive healthcare is significantly boosting the demand for advanced diagnostic solutions.

Key Market Highlights

• North America dominated the market with a 30% share in 2025
• Asia Pacific is expected to grow at the fastest CAGR
• Test kits segment led the market in 2025
• Instruments segment is projected to grow rapidly
• Antibody tests dominated the test type segment
• Nucleic acid tests are expected to grow at the fastest rate
• ELISA technology held the largest market share
• Rapid testing is expected to witness strong growth
• Hospitals dominated the end-user segment
• Home care settings are gaining significant traction

Market Drivers

Rising Awareness of HIV/AIDS

Increased awareness campaigns and education initiatives are encouraging individuals to undergo regular HIV testing. Governments and healthcare organizations are actively promoting early diagnosis to reduce transmission rates.

Growing Prevalence of HIV

The rising number of HIV cases globally is a major factor driving demand for diagnostic solutions. According to global health data, millions of individuals continue to be affected, highlighting the need for efficient testing infrastructure.

Expansion of Healthcare Infrastructure

Rapid investments in healthcare infrastructure, especially in developing countries, are enhancing access to diagnostic services. The establishment of new testing centers and laboratories is supporting market growth.

Government Initiatives and Screening Programs

Governments worldwide are launching large-scale screening programs and initiatives to improve HIV detection and treatment. These efforts are significantly boosting the adoption of diagnostic technologies.

Role of Artificial Intelligence in HIV Diagnostics

Artificial Intelligence (AI) is transforming the HIV diagnostics market by enabling faster, more accurate, and data-driven diagnosis. AI-powered tools analyze complex datasets, including lab reports and genomic information, to detect HIV infections and related complications at earlier stages.

AI also supports predictive analytics, helping healthcare providers forecast treatment outcomes and identify drug resistance patterns. Additionally, AI-based chatbots and digital platforms are improving patient engagement and awareness, making HIV care more accessible.

Key Market Trends

Expansion of HIV Testing Centers

Healthcare organizations are actively establishing new HIV testing centers to improve accessibility and early detection. This trend is particularly strong in high-prevalence regions.

Growth in Home-Based Testing

The demand for home-based HIV testing kits is rising due to increasing preference for privacy and convenience. Self-testing solutions are reducing stigma and encouraging more individuals to get tested.

Product Innovations and Launches

Leading companies are continuously introducing advanced diagnostic products, including rapid testing kits and portable devices, to enhance testing capabilities.

Strategic Partnerships

Collaborations between governments, healthcare providers, and diagnostic companies are strengthening testing infrastructure and expanding product reach.

Segmental Analysis

By Product Type

Test Kits

The test kits segment dominated the market in 2025 due to affordability, ease of use, and widespread adoption across hospitals and community screening programs.

Instruments

The instruments segment is expected to grow at the fastest CAGR, driven by increasing adoption of automated diagnostic systems and advanced laboratory equipment.

By Test Type

Antibody Tests

Antibody tests held the largest market share in 2025, as they are widely used for initial HIV screening due to their reliability and cost-effectiveness.

Nucleic Acid Tests (NAT)

Nucleic acid tests are expected to grow rapidly, as they enable early detection of HIV by identifying viral RNA, reducing the diagnostic window period.

By Technology

ELISA (Enzyme-Linked Immunosorbent Assay)

ELISA dominated the market due to its high sensitivity, specificity, and ability to process large sample volumes, making it ideal for mass screening.

Rapid Testing

Rapid testing is gaining popularity due to its ability to deliver results within minutes, making it suitable for point-of-care and emergency settings.

By End User

Hospitals

Hospitals led the market in 2025 due to their advanced infrastructure, ability to conduct large-scale testing, and comprehensive patient care services.

Home Care Settings

Home care settings are expected to grow significantly, driven by increasing adoption of self-testing kits and rising awareness about early diagnosis.

Regional Insights

North America

North America dominated the HIV diagnostics market in 2025, supported by advanced healthcare systems, strong government initiatives, and high awareness levels. The presence of leading diagnostic companies and continuous technological advancements further strengthen the region’s position.

Asia Pacific

Asia Pacific is expected to witness the fastest growth due to rising HIV prevalence, expanding healthcare infrastructure, and increasing government focus on disease prevention. Countries such as China and India are investing heavily in diagnostic capabilities.

Europe

Europe is also experiencing steady growth, driven by government support, improved healthcare access, and increasing adoption of advanced diagnostic technologies.

Competitive Landscape

The HIV diagnostics market is highly competitive, with major players focusing on innovation, partnerships, and global expansion.

Key Companies Include:

• Abbott
• Roche
• Siemens Healthineers
• QIAGEN
• BD (Becton, Dickinson and Company)
• Beckman Coulter
• Sysmex Corporation
• Alere Inc.
• Gilead Sciences
• Merck & Co.

Recent Developments

• In February 2026, OraSure Technologies launched the OraQuick HIV Self-Test for improved accessibility.
• In June 2025, Cepheid received approval for its advanced HIV viral load testing solution.
• Governments across countries launched initiatives to expand HIV testing services.
• Healthcare organizations opened new HIV testing centers to improve early diagnosis.

Future Outlook

The HIV diagnostics market is expected to grow steadily over the next decade, driven by technological advancements, increasing awareness, and expanding healthcare access. Innovations in rapid testing, molecular diagnostics, and AI integration will continue to shape the future of HIV detection.

The shift toward decentralized testing, including home-based and point-of-care solutions, will further enhance market growth and accessibility.

Conclusion

The global HIV diagnostics market is poised for sustained growth, supported by rising awareness, government initiatives, and technological innovation. As early detection remains crucial in combating HIV, the demand for advanced diagnostic solutions will continue to rise, creating significant opportunities for market players.

Get Sample Copy: https://www.precedenceresearch.com/sample/8020

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com